Table 1. Demographic values for subjects, measures of body mass index and PANSS at baseline and after 3-month program or 3-month interval.
|
Mean (s.d.) |
||||
|---|---|---|---|---|
|
Program group |
Control group |
|||
| Baseline | Outcome | Baseline | Outcome | |
| Age (years) | 43.5 (11.8) | — | 39.9 (13.6) | — |
| Gender (male/female) | 7/6 | — | 5/5 | — |
| Illness duration (years) | 22.1 (15.0) | — | 14.8 (11.7) | — |
| Daily antipsychotics dosage (mg) | 506.8 (426.6) | — | 592.0 (390.3) | — |
| Body mass index | 28.5 (4.7) | 27.8 (4.3) | 26.3 (3.5) | 26.5 (4.5) |
| Positive scale of PANSS | 15.8 (4.2) | 15.5 (3.6) | 13.1 (2.5) | 13.6 (3.3) |
| Negative scale of PANSS | 20.7 (5.3) | 19.8 (5.1) | 20.8 (4.1) | 21.0 (3.7) |
| General psychopathology scale of PANSS | 37.4 (6.7) | 35.0 (7.3) | 35.4 (3.1) | 35.8 (3.5) |
| Total score of PANSS | 73.9 (15.0) | 70.3 (14.8) | 69.3 (4.7) | 70.4 (5.5) |
Abbreviation: PANSS, Positive and Negative Syndrome Scale.